Evidence map›Paper›PMID 36298487›Full record

ArticleVaccines2022

Double Auxotrophy to Improve the Safety of a Live Anti-

Víctor Fuentes-Valverde, Patricia García, Miriam Moscoso, Germán Bou

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Engineering low-endotoxin lipid A in a double auxotrophFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. International journal of molecular sciences · 2025
    Review
  4. Review
  5. LpxR and PagL expression in live attenuated auxotrophicFrontiers in cellular and infection microbiology · 2025
    Article
  6. Transient infection ofApplied and environmental microbiology · 2024
    Article
  7. Unravelling the mechanisms causing murepavadin resistance inFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Víctor Fuentes-ValverdeDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.
Patricia GarcíaDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.ORCID 0000-0002-0418-296X
Miriam MoscosoDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.ORCID 0000-0001-8977-3269
Germán BouDepartment of Microbiology, University Hospital A Coruña (CHUAC), Biomedical Research Institute A Coruña (INIBIC), 15006 A Coruña, Spain.ORCID 0000-0001-8837-0062
Instituto de Salud Carlos III · ESComplexo Hospitalario Universitario A Coruña · ES

Funding

Consello da Cultura Galega IN606A-2019/012Instituto de Salud Carlos III CIBERINFECInstituto de Salud Carlos III PI18/00501Instituto de Salud Carlos III PI21/00704Instituto de Salud Carlos III RD16/0016/0006Servicio Gallego de Salud Program "Innova Microlab"Servicio Gallego de Salud Program "Innova Saúde"
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alanine racemase geneauxotrophyglutamate racemase geneintranasal immunizationlive-attenuated vaccinePseudomonas aeruginosa

Identifiers

PMID36298487
PMCPMC9610692
OpenAlexW4298003315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.